Roche Holding Ltd Sponsored ADR

As of June 30, 2026, Roche Holding Ltd Sponsored ADR carries a market capitalization of 334.42B, placing it among publicly traded companies globally. Its enterprise value stands at 366.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Roche Holding Ltd Sponsored ADR has 6.53B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Roche Holding Ltd Sponsored ADR maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Roche Holding Ltd Sponsored ADR's stock has gained approximately 34.94% over the past 52 weeks. The 50-day moving average sits at 55.20, while the 200-day moving average is 53.40.

As of June 30, 2026, Roche Holding Ltd Sponsored ADR holds 12.05B in cash and equivalents against 39.37B in total debt, resulting in a net debt position of 32.63B. Total book value stands at 40.47B, with working capital of 8.16B providing operational flexibility.

Roche Holding Ltd Sponsored ADR's most recent stock split took place on February 27, 2014 with a 1:2 split ratio.